CLUE: CLinical Utility Study of EsoGuard

Clinical trial NCT06030180 · COMPLETED

Trial details

NCT number: NCT06030180
Sponsor: Lucid Diagnostics, Inc.
Status: COMPLETED
Phase: Not Applicable
Study type: INTERVENTIONAL

Barrett Esophagus Barretts Esophagus With Dysplasia Esophagus Adenocarcinoma

Start date: 2023-02-23
Primary completion: 2024-12-13
Enrollment: 566

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.